About this trial
Septic shock is a critical condition associated with high mortality. Transthoracic echocardiography is widely used to evaluate cardiac function and guide treatment. Left and right atrial strain (LAS and RAS) measured via speckle tracking echocardiography have shown prognostic value in cardiovascular diseases. However, differences exist between echocardiographic software, leading to challenges in result comparability. This study aims to compare LAS and RAS measurements between ECHOPAC and UWS software, evaluate AutoStrain technology, and assess reproducibility across observers. The study is non-interventional and will use retrospective echocardiographic data from patients treated for septic shock. The findings will contribute to improving measurement standardization in critically ill patients.
Eligibility criteria
Qualifiers
Age: >18 years
Adult patients admitted to critical care for septic shock (SEPSIS-3 definition)
TTE performed as part of medical management
No objection to data usage
Disqualifiers
Pregnancy
Moderate to severe valvular regurgitation/stenosis (>grade 2)
Ventricular or supraventricular tachyarrhythmia (HR >140 bpm) at the time of TTE
Poor echogenicity preventing LAS measurement
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Centre Hospitalier Universitaire, Amiens
Lead sponsor
Henri Mondor University Hospital
Collaborator